News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,132 Results
Type
Article (43247)
Company Profile (267)
Press Release (694602)
Multimedia
Podcasts (105)
Webinars (23)
Section
Business (206056)
Career Advice (2117)
Deals (35756)
Drug Delivery (131)
Drug Development (81886)
Employer Resources (173)
FDA (16689)
Job Trends (15088)
News (348913)
Policy (32967)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2669)
Accelerated approval (48)
Adcomms (27)
Allergies (172)
Alliances (50001)
ALS (212)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (458)
Approvals (17082)
Artificial intelligence (691)
Autoimmune disease (296)
Automation (56)
Bankruptcy (367)
Best Places to Work (11701)
BIOSECURE Act (20)
Biosimilars (224)
Biotechnology (173)
Bladder cancer (198)
Brain cancer (73)
Breast cancer (761)
Cancer (5895)
Cardiovascular disease (485)
Career advice (1802)
Career pathing (45)
CAR-T (333)
CDC (58)
Celiac Disease (3)
Cell therapy (912)
Cervical cancer (47)
Clinical research (71163)
Collaboration (2090)
Company closure (5)
Compensation (1417)
Complete response letters (81)
COVID-19 (2761)
CRISPR (108)
C-suite (1150)
Cystic fibrosis (152)
Data (8031)
Decentralized trials (3)
Denatured (35)
Depression (163)
Dermatology (87)
Diabetes (590)
Diagnostics (6962)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (328)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (291)
Earnings (92322)
Editorial (67)
Employer branding (21)
Employer resources (153)
Events (120345)
Executive appointments (1097)
FDA (20467)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1759)
Gene editing (235)
Generative AI (58)
Gene therapy (734)
GLP-1 (1070)
Government (4772)
Grass and pollen (6)
Guidances (410)
Healthcare (19185)
HIV (80)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (295)
Immuno-oncology (94)
Indications (196)
Infectious disease (3106)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (292)
Interviews (344)
IPO (16706)
IRA (50)
Job creations (3681)
Job search strategy (1484)
JPM (58)
Kidney cancer (19)
Labor market (102)
Layoffs (576)
Leadership (46)
Legal (8000)
Liver cancer (100)
Longevity (32)
Lung cancer (776)
Lymphoma (432)
Machine learning (60)
Management (60)
Manufacturing (1062)
MASH (190)
Medical device (14128)
Medtech (14257)
Mergers & acquisitions (20307)
Metabolic disorders (1524)
mRNA (213)
Multiple sclerosis (190)
NASH (17)
Neurodegenerative disease (426)
Neuropsychiatric disorders (105)
Neuroscience (3336)
Neurotech (1)
NextGen: Class of 2026 (6593)
Non-profit (4606)
Now hiring (78)
Obesity (717)
Opinion (304)
Ovarian cancer (227)
Pain (258)
Pancreatic cancer (308)
Parkinson's disease (364)
Partnered (33)
Patents (600)
Patient recruitment (678)
Peanut (62)
People (60080)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22209)
Phase 2 (31343)
Phase 3 (23301)
Pipeline (8935)
Policy (322)
Postmarket research (2585)
Preclinical (9497)
Press Release (65)
Prostate cancer (308)
Psychedelics (54)
Radiopharmaceuticals (331)
Rare diseases (1096)
Real estate (6011)
Recruiting (70)
Regulatory (25608)
Reports (56)
Research institute (2473)
Resumes & cover letters (357)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (180)
Series A (296)
Series B (216)
Service/supplier (11)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3700)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (88)
The Weekly (68)
Vaccines (1104)
Venture capital (113)
Weight loss (465)
Women's health (128)
Worklife (22)
Date
Last 7 days (676)
Last 30 days (3257)
Last 365 days (30217)
2026 (13150)
2025 (30367)
2024 (35389)
2023 (40287)
2022 (51412)
2021 (55948)
2020 (54436)
2019 (46971)
2018 (35350)
2017 (32435)
2016 (31840)
2015 (37899)
2014 (31626)
2013 (26731)
2012 (28978)
2011 (29692)
2010 (27808)
Location
Africa (755)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (14)
Asia (40142)
Australia (6608)
California (13437)
Canada (3800)
China (1371)
Colorado (571)
Connecticut (583)
Delaware (412)
Europe (87634)
Florida (2011)
Georgia (431)
Hawaii (3)
Idaho (63)
Illinois (1070)
India (90)
Indiana (605)
Iowa (23)
Japan (542)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1604)
Massachusetts (9613)
Michigan (366)
Minnesota (733)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3515)
New Mexico (29)
New York (3504)
North Carolina (1712)
North Dakota (9)
Northern California (6738)
Ohio (400)
Oklahoma (24)
Oregon (41)
Pennsylvania (2695)
Puerto Rico (29)
Rhode Island (51)
South America (1133)
South Carolina (86)
South Dakota (2)
Southern California (5311)
Tennessee (214)
Texas (2139)
United States (47388)
Utah (400)
Vermont (1)
Virginia (324)
Washington D.C. (81)
Washington State (1070)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
738,132 Results for "navigate cardiac structures inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter
Heath Secretary Robert F. Kennedy Jr.’s efforts to overhaul vaccine policy are likely illegal, a Massachusetts District Court Judge ruled; Structure’s GLP-1 weight loss pill succeeds in Phase 2 while Rhythm’s Phase 3 basket trial fails to find the beat; Eli Lilly warns of potential safety risks of taking compounded tirzepatide, and Novo Nordisk is hit with an FDA warning letter regarding adverse events potentially linked to Ozempic.
March 18, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
May 7, 2026
·
6 min read
Press Releases
ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
May 19, 2026
·
5 min read
Obesity
Structure Climbs on ‘Highly Competitive’ Profile for Weight Loss Pill
Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial. The biotech is planning to launch a late-stage program for the drug later this year.
March 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin
May 22, 2026
·
6 min read
Press Releases
Corify Care Receives FDA Clearance for ACORYS® -- Introducing Instant, 4-D Electroanatomical Cardiac Mapping in Real-time
April 17, 2026
·
3 min read
Press Releases
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 16, 2026
·
5 min read
Press Releases
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
December 1, 2025
·
13 min read
Press Releases
Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial
May 22, 2026
·
6 min read
Press Releases
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
April 7, 2026
·
7 min read
1 of 73,814
Next
